Disclosure Panels Details Page
Pediatric Soft Tissue Sarcoma Panel - Disclosures as of 04/19/2024
|
Panel Member
(Spouse/Domestic Partner/Dependent) |
Clinical Research Support/Data Safety Monitoring Board | Scientific Advisory Boards, Consultant, or Expert Witness | Promotional Advisory Boards, Consultant, or Speakers Bureau | Employment/ Governing Board, Patent, Equity, or Royalty | Date Completed |
|---|---|---|---|---|---|
| Alyaa Al-Ibraheemi MD | None | None | None | None | 02/26/2024 |
| Wendy Allen-Rhoades PhD,MD | Children's Oncology Group | US WorldMeds LLC | None | None | 04/19/2024 |
| Daniel Appelbaum MD | None | None | None | None | 01/29/2024 |
| Raffi Avedian MD | None | None | Springworks | None | 03/15/2024 |
| Jill Beck MD | None | None | None | None | 04/17/2024 |
| Marian Birkeland PhD | None | None | None | None | 04/02/2024 |
| Nicole Blankenhorn | None | None | None | None | 03/04/2024 |
| Scott Borinstein PhD,MD | None | Expert Witness, Legal Foundation Medicine |
None | None | 12/14/2023 |
| Barrett Cromeens PhD,DO | None | None | None | None | 04/05/2024 |
| Douglas Fair MS,MD | None | None | None | None | 01/16/2024 |
| Kristina Gregory MSN,RN | None | None | None | None | 01/10/2024 |
| Ajay Gupta MD | None | None | None | None | 03/11/2024 |
| Evelyn Handel PharmD,BCPS,BCOP | None | None | None | None | 02/02/2024 |
| Douglas Harrison MD | None | None | None | None | 04/11/2024 |
| Douglas Hawkins MD | None | None | None | None | 03/12/2024 |
| Erin Hesler | None | None | None | None | 12/22/2023 |
| Cindy Hochstetler PhD | None | None | None | None | 02/16/2024 |
| Theodore Laetsch MD | Bayer HealthCare Bristol Myers Squibb Eli Lilly and Company Exelixis Inc. Genentech, Inc. Jazz Pharmaceuticals Inc. Novartis Pharmaceuticals Corporation Pfizer Inc. |
Advanced Microbubbles AI Therapeutics Bayer HealthCare GentiBio ITM Oncologics Jazz Pharmaceuticals Inc. MassiveBio Menarini Novartis Pharmaceuticals Corporation Pyramid Biosciences Treeline Bio |
None | None | 01/02/2024 |
| Nicole Larrier MSc,MD | None | None | None | None | 03/26/2024 |
| Daniel Lui PharmD,BCPPS | None | None | None | None | 04/09/2024 |
| Sara Mansfield MD,MS | None | None | None | None | 01/30/2024 |
| Beth McCullough CMSRN,RN,BS | None | None | None | None | 12/13/2023 |
| Jonathan Metts MD | Bristol Myers Squibb | None | None | None | 01/03/2024 |
| Sarah Milgrom MD | None | Bristol Myers Squibb | None | None | 03/16/2024 |
| Lorenzo Nardo PhD,MD | Curium European Commission General Electric NIH: I am the Co-Pi of 2 NIH grants as reported in NIH RePORT Novartis Pharmaceuticals Corporation Progenics/lantheus Telix Pharmaceuticals United Imaging Healthcare |
Eli Lilly and Company | None | None | 04/02/2024 |
| Alberto Pappo MD | Eli Lilly and Company Iovance pharmaceuticals Merck & Co., Inc. Pfizer Inc. |
None | None | None | 02/26/2024 |
| Donna Powell CMD,DHSc,RT(T) | None | None | None | None | 03/13/2024 |
| Christine Pratilas MD | Kura Oncology, Inc. NACHO- North American Consortium for Histiocytosis |
None | None | None | 04/09/2024 |
| Raja Rabah MD | None | None | None | None | 03/22/2024 |
| Jennifer Reichek MSW,MD | None | None | None | None | 02/26/2024 |
| Stephen Skapek MD | None | None | None | None | 03/17/2024 |
| Emily Slotkin MD | Bristol Myers Squibb Eli Lilly and Company Esperas Pharmaceuticals Y-mAbs Therapeutics |
Guidepoint Consultants Inbrx Pharmaceuticals |
None | None | 03/14/2024 |
| Jonathan Swanson MBA,MD | None | None | None | None | 03/15/2024 |
| Samantha Tamburro OCN,RN,BSN | None | None | None | None | 12/08/2023 |
| Lauren Wessel MD | None | None | None | None | 03/13/2024 |
| Janet Yoon MD | None | None | None | None | 03/25/2024 |